Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 133Precursor Cell Lymphoblastic Leukemia-Lymphoma 118Myelodysplastic Syndromes 107Lymphoma, Non-Hodgkin 90Leukemia, Lymphocytic, Chronic, B-Cell 85Hodgkin Disease 84Leukemia 81Multiple Myeloma 80Lymphoma, Mantle-Cell 63Lymphoma 63Lymphoma, Follicular 59Leukemia, Myelogenous, Chronic, BCR-ABL Positive 59Myeloproliferative Disorders 55Lymphoma, B-Cell, Marginal Zone 53Leukemia, Myelomonocytic, Chronic 50Burkitt Lymphoma 50Lymphoma, Large B-Cell, Diffuse 49Hematologic Neoplasms 42Congenital Abnormalities 42Lymphoma, Large-Cell, Immunoblastic 36Leukemia, Myeloid, Accelerated Phase 35Leukemia, Myeloid, Chronic-Phase 34Anemia, Refractory, with Excess of Blasts 34Waldenstrom Macroglobulinemia 33Primary Myelofibrosis 32Leukemia, Biphenotypic, Acute 32Lymphoma, Large-Cell, Anaplastic 28Blast Crisis 28Lymphoma, T-Cell, Cutaneous 27Dendritic Cell Sarcoma, Interdigitating 26

Interventions

fludarabine phosphate 1Whole-Body Irradiation 1Thiotepa 1Standard of Care 1Melphalan 1Cyclophosphamide 1Clinical Trials, Phase I as Topic 1Busulfan 1Antilymphocyte Serum 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Metabolism, Inborn Errors × Whole-Body Irradiation × Clear all
NCT01049854 2018-08-21

CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor Transplant

New York Medical College

Phase 2 Completed
20 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Bone Marrow Failure Disorders, Anemia, Sickle Cell, Immunologic Deficiency Syndromes, Leukemia, Lymphoma, Metabolism, Inborn Errors, Histiocytosis, beta-Thalassemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡